PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.38%
Revenue growth under 50% of AMD's 12.03%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.44%
Gross profit growth under 50% of AMD's 13.99%. Michael Burry would be concerned about a severe competitive disadvantage.
1.49%
EBIT growth below 50% of AMD's 21.54%. Michael Burry would suspect deeper competitive or cost structure issues.
4.16%
Operating income growth under 50% of AMD's 15.04%. Michael Burry would be concerned about deeper cost or sales issues.
0.83%
Net income growth under 50% of AMD's 30.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.96%
EPS growth under 50% of AMD's 31.03%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.98%
Diluted EPS growth under 50% of AMD's 29.31%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
14.47%
Positive OCF growth while AMD is negative. John Neff would see this as a clear operational advantage vs. the competitor.
11.93%
Positive FCF growth while AMD is negative. John Neff would see a strong competitive edge in net cash generation.
66.03%
10Y revenue/share CAGR 1.25-1.5x AMD's 51.17%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
37.03%
5Y revenue/share CAGR under 50% of AMD's 117.73%. Michael Burry would suspect a significant competitive gap or product weakness.
14.40%
3Y revenue/share CAGR under 50% of AMD's 140.28%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
164.44%
10Y OCF/share CAGR in line with AMD's 166.09%. Walter Schloss would see both as similarly efficient over the decade.
86.38%
Below 50% of AMD's 1831.64%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
21.04%
3Y OCF/share CAGR under 50% of AMD's 723.00%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
301.53%
Net income/share CAGR at 50-75% of AMD's 463.66%. Martin Whitman might question if the firm’s product or cost base lags behind.
118.16%
Below 50% of AMD's 250.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
30.19%
Below 50% of AMD's 733.33%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
36.59%
Below 50% of AMD's 142.38%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
28.13%
Below 50% of AMD's 1122.95%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
21.31%
Below 50% of AMD's 484.14%. Michael Burry suspects a serious short-term disadvantage in building book value.
688.88%
Dividend/share CAGR of 688.88% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.47%
Dividend/share CAGR of 167.47% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
64.28%
3Y dividend/share CAGR of 64.28% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
3.90%
AR growth is negative/stable vs. AMD's 10.02%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.38%
Inventory shrinking or stable vs. AMD's 7.76%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
12.96%
Asset growth above 1.5x AMD's 4.32%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.95%
BV/share growth above 1.5x AMD's 0.47%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
23.80%
Debt growth far above AMD's 5.24%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.77%
Our R&D shrinks while AMD invests at 16.08%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.06%
We cut SG&A while AMD invests at 7.92%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.